Ibuclin Junior 100 mg/125 mg Tablet is a combination analgesic and antipyretic formulation containing ibuprofen 100 mg and paracetamol 125 mg, indicated for the relief of mild to moderate pain and fever in pediatric patients. Ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins involved in pain and inflammation. Paracetamol, also known as acetaminophen, acts centrally to alleviate pain and reduce fever through inhibition of the cyclooxygenase pathway in the central nervous system. This synergistic combination provides enhanced analgesic and antipyretic efficacy compared to either agent alone, making it suitable for conditions such as headache, dental pain, musculoskeletal discomfort, and febrile illnesses in children. Ibuclin Junior should be administered according to the prescribed dosage based on the child’s age and weight, with careful adherence to recommended intervals to avoid overdose. Caution is advised in patients with hepatic or renal impairment, hypersensitivity to NSAIDs or paracetamol, and in those with a history of gastrointestinal disorders. As with all medications, healthcare professional consultation is essential prior to use to ensure safety and appropriateness of therapy.